Glycaemic control and vascular complications in type 2 diabetes: new observations and clinical significance.
J Indian Med Assoc
;
2008 Nov; 106(11): 724-6
Article
in English
| IMSEAR
| ID: sea-103811
ABSTRACT
Whether intensive gylcaemic control can reduce the cardiovascular complications in type 2 diabetes has been answered in three clinical trials (ACCORD, ADVANCE and VADT). All three studies measured microvascular complications as well as macrovascular end points. It is important to initiate intensive glycaemic control early in the course of diabetes. Type 2 diabetes mellitus patients require lifestyle modification plus combinations of insulin sensitisers and insulin secretagogues. It target glycaemic control is not achieved then either incretin minetics or insulin can be added.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Aged
/
Humans
/
Comorbidity
/
Randomized Controlled Trials as Topic
/
Treatment Outcome
/
Thiazolidinediones
/
Diabetes Mellitus, Type 2
/
Diabetic Angiopathies
/
Hyperglycemia
/
Hypoglycemic Agents
Type of study:
Controlled clinical trial
Language:
English
Journal:
J Indian Med Assoc
Year:
2008
Type:
Article
Similar
MEDLINE
...
LILACS
LIS